Richard M. Hoffman and Charles Wiggins are with the University of New Mexico School of Medicine and the University of New Mexico Cancer Center, Albuquerque. Richard M. Hoffman is also with the New Mexico VA Health Care System, Albuquerque. Jun Li and Umed A. Ajani are with the Centers for Disease Control and Prevention (CDC), Atlanta, GA. Jeffrey A. Henderson is with the Black Hills Center for American Indian Health, Rapid City, SD.
Am J Public Health. 2014 Jun;104 Suppl 3(Suppl 3):S439-45. doi: 10.2105/AJPH.2013.301690. Epub 2014 Apr 22.
We linked databases to improve identification of American Indians/Alaska Natives (AI/ANs) in determining prostate cancer death and incidence rates.
We linked prostate cancer mortality and incidence data with Indian Health Service (IHS) patient records; analyses focused on residents of IHS Contract Health Service Delivery Area (CHSDA) counties. We calculated age-adjusted incidence and death rates for AI/AN and White men for 1999 to 2009; men of Hispanic origin were excluded.
Prostate cancer death rates were higher for AI/AN men than for White men. Death rates declined for White men (-3.0% per year) but not for AI/AN men. AI/AN men had lower prostate cancer incidence rates than White men. Incidence rates declined among Whites (-2.2% per year) and AI/ANs (-1.9% per year).
AI/AN men had higher prostate cancer death rates and lower prostate cancer incidence rates than White men. Disparities in accessing health care could contribute to mortality differences, and incidence differences could be related to lower prostate-specific antigen testing rates among AI/AN men.
通过数据库链接，提高美国印第安人/阿拉斯加原住民（AI/AN）在确定前列腺癌死亡率和发病率方面的识别率。
我们将前列腺癌死亡率和发病率数据与印第安人健康服务（IHS）患者记录相关联；分析集中在 IHS 合同医疗服务提供区（CHSDA）县的居民。我们计算了 1999 年至 2009 年 AI/AN 和白人男性的年龄调整发病率和死亡率；排除了具有西班牙裔血统的男性。
AI/AN 男性的前列腺癌死亡率高于白人男性。白人男性的死亡率下降（每年-3.0%），但 AI/AN 男性的死亡率没有下降。AI/AN 男性的前列腺癌发病率低于白人男性。白人男性（每年-2.2%）和 AI/AN 男性（每年-1.9%）的发病率均下降。
AI/AN 男性的前列腺癌死亡率高于白人男性，发病率低于白人男性。获得医疗保健的差异可能导致死亡率的差异，而发病率的差异可能与 AI/AN 男性中较低的前列腺特异性抗原检测率有关。
